Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Effects of Petrosaspongiolide M, a Novel Phospholipase A2 Inhibitor, on Acute and Chronic Inflammation

Pablo Garcia-Pastor, Antonio Randazzo, Luigi Gomez-Paloma, M. Jose Alcaraz and Miguel Paya
Journal of Pharmacology and Experimental Therapeutics April 1999, 289 (1) 166-172;
Pablo Garcia-Pastor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Randazzo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luigi Gomez-Paloma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Jose Alcaraz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Paya
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The marine product petrosaspongiolide M is a novel inhibitor of phospholipase A2 (PLA2), showing selectivity for secretory PLA2 versus cytosolic PLA2, with a potency on the human synovial enzyme (group II) similar to that of manoalide. This compound was more potent than manoalide on bee venom PLA2 (group III) and had no effect on group I enzymes (Naja naja and porcine pancreatic PLA2). Inhibition of PLA2 was also observed in vivo in the zymosan-injected rat air pouch, on the secretory enzyme accumulated in the pouch exudate. Petrosaspongiolide M decreased carrageenan paw edema in mice after the oral administration of 5, 10, or 20 mg/kg. This marine metabolite (0.01–1.0 μmol/pouch) induced a dose-dependent reduction in the levels of prostaglandin (PG)E2, leukotriene B4, and tumor necrosis factor-α in the mouse air pouch injected with zymosan 4 h after the stimulus. It also had a weaker effect on cell migration. The inflammatory response of adjuvant arthritis was reduced by petrosaspongiolide M, which also inhibited leukotriene B4 levels in serum and PGE2 levels in paw homogenates. In contrast with indomethacin, this marine compound did not reduce PGE2levels in stomach homogenates. Petrosaspongiolide M is a new inhibitor of secretory PLA2 in vitro and in vivo, with anti-inflammatory properties in acute and chronic inflammation.

Footnotes

  • Send reprint requests to: Dr. M. Payá, Departamento de Farmacologı́a, Universidad de Valencia, Facultad de Farmacia, Avda. Vicent Andrés Estellés s/n, 46100 Burjassot, Valencia, Spain. E-mail Miguel.paya{at}uv.es

  • ↵1 This work was supported by Grant SAF98–0119 from Comisión Interministeñal de Ciencia y Tecnología, Spanish Ministerio de Educación y Ciencia.

  • Abbreviations:
    PLA2
    phospholipase A2
    sPLA2
    secretory phospholipase A2
    cPLA2
    cytosolic phospholipase A2
    COX-1
    cyclooxygenase-1
    COX-2
    cyclooxygenase-2
    5-LO
    5-lipoxygenase
    LPS
    lipopolysaccharide
    LT
    leukotriene
    iNOS
    inducible nitric oxide synthase
    NSAID
    nonsteroidal anti-inflammatory drug
    PG
    prostaglandin
    TNF-α
    tumor necrosis factor-α
    TXB2
    thromboxane B2
    • Received August 25, 1998.
    • Accepted November 3, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 289 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 289, Issue 1
1 Apr 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Effects of Petrosaspongiolide M, a Novel Phospholipase A2 Inhibitor, on Acute and Chronic Inflammation
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Effects of Petrosaspongiolide M, a Novel Phospholipase A2 Inhibitor, on Acute and Chronic Inflammation

Pablo Garcia-Pastor, Antonio Randazzo, Luigi Gomez-Paloma, M. Jose Alcaraz and Miguel Paya
Journal of Pharmacology and Experimental Therapeutics April 1, 1999, 289 (1) 166-172;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Effects of Petrosaspongiolide M, a Novel Phospholipase A2 Inhibitor, on Acute and Chronic Inflammation

Pablo Garcia-Pastor, Antonio Randazzo, Luigi Gomez-Paloma, M. Jose Alcaraz and Miguel Paya
Journal of Pharmacology and Experimental Therapeutics April 1, 1999, 289 (1) 166-172;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Discriminative Stimulus Effects of Zolpidem in Squirrel Monkeys: Comparison with Conventional Benzodiazepines and Sedative-Hypnotics
  • Use-Dependent ‘Agonist’ Effect of Azimilide on the HERG Channel
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics